Life Sciences Archive » January, 2009

Life Sciences - January, 2009

146 articles

• GSK Records $400M Legal Charge In Off-Label Probe
• BASF Told To Pay Insurers $1.7M In Synthroid Suit
• EPA Extends Comment Period On Drug Waste Rule
• Judge Refuses To Dismiss Lexapro Declaratory Action
• Pfizer Garners Win In Viagra MDL Discovery Spat
• 2nd Circ. Revives Nigerian Families' Case V. Pfizer
• Lilly Officially Pleads Guilty In Zyprexa Debacle
• Divestiture Paves Way For Getinge, Datascope Merger
• CB Fleet, 7 Plaintiffs Settle Bowel Cleanser Suits
• High Court Asked To Weigh Inequitable Conduct Ruling
• Democrats Unveil Revised Import Safety Bill
• Discovery To Proceed In NFL StarCaps Suit: Judge
• Nearly 250 Mirapex Plaintiffs Settle In MDL
• Fed. Circ. Braces For Overhaul As Retirements Loom
• Lilly Sues Invagen Over Osteoporosis Drug Evista
• Third-Party Enforcement For Counterfeiting
• 2nd Circ. Tosses Securities Suit Over Bextra, Celebrex
• Post-EBay: Permanent Injunctions, Future Damages
• Judge Sets Deadline For Prempro MDL Discovery
• FDA Warns Of Addictive Drug In Bodybuilding Pills
• Crowell Hires Former FDA Official As Consultant
• Judge Tosses 2 Cases In Seroquel MDL
• Troubled KV Issues Near-Total Recall
• Medtronic, BSC Agree To Halt 5 Patent Spats
• Invention Incentive Programs Get Results: Survey
• Senate Judiciary Committee OKs Holder In 17-2 Vote
• Supreme Court Asked To Weigh In On Bilski Case
• Is Your Application Ready Under KSR?
• Aventis Files Another Patent Suit Over Allegra
• Caraco Hits Forest Over 3rd Lexapro Patent
• Pfizer To Pay $2.3B In Bextra Off-Label Marketing Suit
• P&G, Roche Sue Sun Over Generic Actonel ANDA
• Baxter Sues Rival Over Anesthetic Container Patent
• FDA's Protection Powers 'Hampered': GAO
• FDA, Drug Cos. To Review Blood Thinner Plavix
• Caliper Sues Shimadzu Over DNA Research Patents
• The Rise In Litigation From FCPA Enforcement
• Court Asks Parties For Input In Medtronic MDL
• Economic Analysis In Off-Label Promotion Cases
• Minn. High Court To Mull Negligence-Claim Time Limit
• Cordis Loses Bid For More Discovery In Patent Suit
• Pfizer, Wyeth Merger May Test Obama FTC's Mettle
• India Plans Overhaul Of Patent Application System
• Elan Sues Alcon Over Eye Treatment Azopt
• P&G, Sanofi's Actonel Dragged Into Fosamax MDL
• Revisions To The AdvaMed Code Of Ethics
• Most Claims Survive In US Bioservices IP Suit
• Calif. Supreme Court Declines To Hear Conte Case
• Insurers To Reduce Liens On Vioxx Settlement Awards
• Former USPTO Judge Leaves Venable For Proskauer
• Conte V. Wyeth Spotlights 'Pioneer Liability' Claims
• Womble Carlyle Expands Life Sciences Patent Unit
• 2 Of King's Skelaxin Patents Invalidated
• Novel Hits Back With Antitrust Charges In Patent Suit
• Medical Groups Dismissed From Prempro MDL
• Account Exec Cut From RICO Suit Against CMH
• ANDAs Must Include All Bioequivalence Data: FDA
• House Panel To Mull BPA Ban In Baby Products
• Judge Tosses Kickback Suit Against Stryker
• IP Joint Ownership Creates Challenges For Cos.
• Travelers Units Deny Heparin Claims Obligations
• M&A Practice: White & Case
• Merck Strikes Teva With 3rd Singulair Suit
• Warner Chilcott Brings New Patent Suit Over Doryx
• New Mass. Patent Rules A Boon After TS Tech
• AstraZeneca Fires Off New Suit Over Nexium Patents
• SEC Slaps Medical Supply Cos., CEO With Fraud Suit
• 3 Reasons NJ May Be New IP Venue Of Choice
• Judge Blasts Centocor Bid In Humira Patent Case
• Andrx, Sciele Sue Lupin Over Diabetes Drug ANDA
• Surgery Toolmakers Settle Drill Guide Suit
• Judge Slams 'Boilerplate' Prempro Claims
• Covidien Settles With Rochester Medical For $3.5M
• Novartis Beats Sales Reps' Wage-And-Hour Suit
• Oscient Files Patent Suit Over Cholesterol Drug
• IP Practice: Dechert
• Taiwan HIV Hemophiliac Cases Head Back To Calif.
• FDA Releases New Safety Guidelines
• Former NFL Player Sues Plan Over Disability Benefits
• GAO Tells FDA To Toughen Class III Device Review
• $1.4B Zyprexa Deal Could Spark More Qui Tam Suits
• Plaintiffs' Experts In '08 Securities Class Actions
• Fed. Circ. Finds Boston Scientific Patent Invalid
• FDA Unveils Final Rules On Engineered Animals
• Judge OKs $20M DIP Financing For Equal Maker
• Wyeth, Pfizer Push To Get Prempro MDL Tossed
• Mylan, Barr, Sandoz Sued Over ANDAs For Solodyn
• 9th Circ. Revives Hytrin Saga
• Lilly Set To Hand Over $1.4B Zyprexa Payout: Report
• Indevus Investors Sue To Halt Endo Merger
• Infringement Claims Nixed In Focalin Patent Suits
• Law Firm In Foltx Patent Suit Not In Conflict: Judge
• FDA Appoints 2 To Bolster Global Programs, IT
• Pioneer Liability After Conte V. Wyeth
• QLT Could Pay Mass. Hospital $113M In Visudyne Case
• AstraZeneca Slaps Biovail Over Seroquel XR
• Preemption: Coming To A Court Near You In 2009
• Judge Looks To Wipe Out Medtronic MDL
• FDA OKs Journal Articles Promoting Off-Label Uses
• Sanofi Slaps Novo Nordisk Over Safety Needle Patent
• HHS Slams FDA Over Conflict-Of-Interest Monitoring
• Equal Maker Seeks Access To $20M In DIP Cash
• Warner Chilcott, Watson Settle Birth Control Dispute
• Sidley Life Sciences Duo Jump To Baker Botts
• Alcon Itches For Fight Over Allergy Eyedrops Patent
• Citing KSR, Fed. Circ. Dismisses Suit V. RealNetworks
• Trial Lawyers Call For Preemption Overhaul
• Illegal Diet Pills Pose Serious Risks, FDA Warns
• US Ignores Link Between Vaccines, Autism: Suit
• CoreValve Beats Edwards' Infringement Suit In UK
• Business Not So Sweet As Equal Maker Enters Ch. 11
• Drug Industry Critic Tapped For FDA Seat
• Alzheimer's Patients Could Die From Risperdal: Study
• Investor Sues Medtronic Over Alleged Infuse Scheme
• Pa. Presses To Wage Vioxx Battle On State Turf
• Galderma Sues Paddock Over Clobex ANDA
• Wyeth Hits Another Generics Maker Over Effexor XR
• An Eye On Revising The FCA
• Zicam Cold Remedy Took User's Sense Of Smell: Suit
• Suit Targets Impax's Move To Sell Generic Amrix
• FDA Finds More Chemical Traces In Baby Formula
• FDA Eyed Over $1.5M Consulting Contract
• Claims Over Drugs Used To Make Meth May Yet Fly
• Breckenridge Challenges Everett's Vitamin Patents
• Fed. Circ. Hears Arguments In Kubin Biotech Case
• Roche Drops Patent From Suits Over Generic Boniva
• Bradley Pharma Settles Securities Suit For $3.5M
• $100M Superfund Settlement Propels NJ Cleanup
• Dey LP Strikes $5M Deal In State Court AWP Case
• The CBO's Take On Health Care Reform
• Canada Issues Renewed Warning Over Chantix
• Becton Dickinson To Settle UltiMed Antitrust Suit
• Schering Faces Antitrust Suit Over Albuterol Prices
• Judge Tosses Medtronic MDL On Preemption Grounds
• Plaintiffs Seek Lift Of Stay In McKesson Antitrust Suits
• Drug Cos. Not Liable For Meds Used In Meth: 8th Circ.
• Abbott Strikes Back At Bayer Patent Suit Over Humira
• Teva, Mass. Settle Drug Price-Fixing Suit For $7M
• Raising The Bar For Securities Fraud Complaints
• Pozen Sues Alphapharm, Mylan Over Generic Treximet
• Samsung, Radio Shack Sued Over Cable Patent
• Merck's Fosamax May Boost Cancer Risk: FDA Official
• FDA Issues Guidance On OTC Drug Labeling Rules
• J&J Sales Rep Exempt From OT Under FLSA: Judge
• Alexion To Pay $25M To Settle Soliris Suit
• Strategies In The War Against Obviousness